2020
Recognizing Axial Spondyloarthritis: A Guide for Primary Care
Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clinic Proceedings 2020, 95: 2499-2508. PMID: 32736944, DOI: 10.1016/j.mayocp.2020.02.007.Peer-Reviewed Original ResearchConceptsInflammatory back painBack painAxial spondyloarthritisHuman leukocyte antigen-B27 positivityChronic low back painNonsteroidal anti-inflammatory drugsExtra-articular manifestationsAge 45 yearsChronic back painLow back painAnti-inflammatory drugsEnglish-language articlesButtock painMorning stiffnessPeripheral arthritisSymptom onsetB27 positivityInsidious onsetAxial SpASpA featuresPrimary careEarly recognitionActive axSpAEffective therapyFamily history
2015
IL-17 Inhibition in Axial Spondyloarthritis
Danve A, Deodhar A. IL-17 Inhibition in Axial Spondyloarthritis. Current Treatment Options In Rheumatology 2015, 1: 221-230. DOI: 10.1007/s40674-015-0020-9.Peer-Reviewed Original ResearchIL-23/ILIL-17IL-23Monoclonal antibodiesExtra-articular manifestationsTNF-α blockadeIL-17 inhibitionIL-23 receptorQuality of lifeSignificant beneficial effectDisease activityProspective trialRadiographic progressionInhibitor medicationIL-12MRI scoresPhysical functionAxial spondyloarthritisClinical studiesP40 subunitAnimal modelsBeneficial effectsWestern populationsNovel optionSpondyloarthritis